18.22M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cells to target particularly challenging liquid and solid tumor oncology indications.

Similar securities

Based on sector and market capitalization

Report issue